So you've been diagnosed
We have some work to do
Common cancer types
Lung cancer, colorectal cancer, breast cancer for women and prostate cancer for men are the most frequent from over 200 different types of cancer
The basic modalities of surgery, radiotherapy and chemotherapy are now being enhanced or even replaced by personalised targeted therapies and/or immunotherapy
Precision Immuno Oncology
By analysing the complex genomic make-up of a cancer, advances in matching patient to treatment are improving survival
A new era of matching patient to treatment clinical trial designs are bringing new drugs to market faster
By mapping the blueprint of a cancer at multiple levels, options can be made available
By being there to walk through and talk through the complex cancer pathway a lot of the anxiety associated with a cancer diagnosis can be alleviated
Backed by science, driven by compassion
Our plan is to step you through each stage of your cancer journey, and promise to give honest guidance and advice.
Sequencing involves extracting the building blocks (DNA) from the cancer, identifying the aberrations, measuring the quality of this information, matching the errors to therapies and/or clinical trials where possible.
We work directly with your team to ensure that the most up-to-date information is always shared. Our experts are able to discuss and analyse their findings with your team, making sure that your treatment is always particular to you.
From mapping comes understanding, and it is that understanding that empowers you & your team, allowing you to feel more in control of your own diagnosis and treatment options. With the knowledge our team can provide, you will be equipped to begin your treatment pathway with your medical team confidently.
Why sequence your tumour
The current standard treatments for cancer (surgery, chemotherapy and radiation therapy) do not specifically target the unique cause of cancer in an individual. Due to a cancers resistance or sensitivity to any given treatments, standard treatments can result in little improvement in survival and significant over-treatment. Newer guided treatments, such as targeted therapy and immunotherapy, rely on simple tests (biomarkers) to guide treatment, however these tests do not assess the underlying genetic sensitivity a cancer may have to these treatments.
By mapping the genetic make-up of a tumour through sequencing, a more complete picture of what makes the cancer grow and spread can be achieved. Understanding these cancer growth pathways can allow for specific treatment strategies on an individual basis. Tumour sequencing may also allow for the identification of relevant clinical trials exploring new treatment strategies for cancers with the same genetic profile. As the technology behind the complex mathematical analysis of genetic sequencing information (bioinformatics) improves, future reanalysis of existing tumour sequencing information may also identify new treatment options.